Fusion of the human cytomegalovirus pp65 antigen with both ubiquitin and ornithine decarboxylase additively enhances antigen presentation to CD8 + T cells in human dendritic cells

Human Gene Therapy

Volumn 21, Issue 8, 2010, Pages 957-967

  Park, Min Ji ^a   Kim, Eun Kyung ^a   Han, Ji Young ^a   Cho, Hyun Woo ^a   Sohn, Hyun Jung ^a   Kim, Su Yeon ^a   Kim, Tai Gyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; ORNITHINE DECARBOXYLASE; UBIQUITIN;

ANTIGEN PRESENTING CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; ELECTROPORATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; DENDRITIC CELLS; ELECTROPORATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ORNITHINE DECARBOXYLASE; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; UBIQUITIN; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 77955501940     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.216     Document Type: Article

References (37)

1. Andersson, H.A., and Barry, M.A. (2004). Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol. Ther. 10, 432-446.
2. Baumeister, W., Walz, J., Zühl, F., and Seemüller, E., (1998). The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92, 367-380.
3. Benaroudj, N., Tarcsa, E., Cascio, P., and Goldberg, A.L. (2001). The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie 83, 311-318.
4. Bercovich, Z., Rosenberg-Hasson, Y., Ciechanover, A., and Ka-hana, C. (1989). Degradation of ornithine decarboxylase in re-ticulocyte lysate is ATP-dependent but ubiquitin-independent. J. Biol. Chem. 264, 15949-115852
5. Butt, T.R., Khan, M.I., Marsh, J., Ecker, D.J., and Crooke, S.T. (1988). Ubiquitin-metallothionein fusion protein expression in yeast: A genetic approach for analysis of ubiquitin functions. J. Biol. Chem. 263, 16364-16371.
6. Coleman, C.S., Stanley, B.A., Viswanath, R., and Pegg, A.E. (1994). Rapid exchange of subunits of mammalian ornithine decarboxylase. J. Biol. Chem. 269, 3155-3158.
7. Davis, R.H., Morris, D.R., and Coffino, P. (1992). Sequestered end products and enzyme regulation: The case of ornithine decarboxylase. Microbiol. Rev. 56, 280-290.
8. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
9. Hoyt, M.A., Zhang, M., and Coffino, P. (2003). Ubiquitin-independent mechanisms of mouse ornithine decarboxylase degradation are conserved between mammalian and fungal cells. J. Biol. Chem. 278, 12135-12143.
10. \+ T cells induced by the ubiquitin fusion degradation pathway. Biochem. Biophys. Res. Commun. 365, 758-763.
11. Johnson, E.S., Bartel, B., Seufert, W., and Varshavsky, A. (1992). Ubiquitin as a degradation signal. EMBO J. 11, 497-505.
12. Krappmann, D., Wulczyn, F.G., and Scheidereit, C. (1996). Different mechanisms control signal-induced degradation and basal turnover of the NF-kB inhibitor IkB a in vivo. EMBO J. 15, 6716-6726.
13. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P.M., Klein, G., Kurilla, M.G., and Masucci, M.G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688.
14. Li, X., and Coffino, P. (1993). Degradation of ornithine dec-arboxylase: Exposure of the C-terminal target by a polyamine-inducible inhibitory protein. Mol. Cell. Biol. 13, 2377-2383.
15. Matsuzawa, S., Cuddy, M., Fukushima, T., and Reed, J.C. (2005). Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway. Proc. Natl. Acad. Sci. U.S.A. 102, 14982-14987.
16. Michalek, M.T., Grant, E.P., Gramm, C., Goldberg, A.L., and Rock, K.L. (1993). A role for the ubiquitin-dependent proteo-lytic pathway in MHC class I-restricted antigen presentation. Nature 363, 552-554.
17. Michiels, A., Tuyaerts, S., Bonehill, A., Corthals, J., Breckpot, K., Heirman, C., van Meirvenne, S., Dullaers, M., Allard, S., Brasseur, F., van der Bruggen, P., and Thielemans, K. (2005). Electroporation of immature and mature dendritic cells: Implications for dendritic cell-based vaccines. Gene Ther. 12, 772-782.
18. Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K., and Gottlieb, D. (2007). Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 13, 707-714.
19. Mosca, F., and Pugni, L. (2007). Cytomegalovirus infection: The state of the art. J. Chemother. 2, 46-48.
20. \+ T-cell immunity to cyto-megalovirus. Hum. Immunol. 65, 456-464.
21. Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K., and Ichihara, A. (1992). Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597-599.
22. Murakami, Y., Matsufuji, S., Hayashi, S., Tanahashi, N., and Tanaka, K. (2000). Degradation of ornithine decarboxylase by the 26S proteasome. Biochem. Biophys. Res. Commun. 267, 1-6.
23. Perret, R., and Ronchese, F. (2008). Memory T cells in cancer immunotherapy: Which CD8 T-cell population provides the best protection against tumours? Tissue Antigens 72, 187-194.
24. Reusser, P., Riddell, S.R., Meyers, J.D., and Greenberg, P.D. (1991). Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
25. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
26. Rodriguez, F., Zhang, J., and Whitton, J.L. (1997). DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71, 8497-8503.
27. Rosenberg-Hasson, Y., Bercovich, Z., Ciechanover, A., and Kahana, C. (1989). Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur. J. Biochem. 185, 469-474.
28. Rouard, H., Klonjkowski, B., Marquet, J., Lahet, C., Mercier, S., Andrieu, M., Maison, P., Molinier-Frenkel, V., Eloit, M., Farcet, J.P., Langlade-Demoyen, P., and Delfau-Larue, M.H. (2003). Adenoviral transgene ubiquitination enhances mouse immunization and class I presentation by human dendritic cells. Hum. Gene Ther. 14, 1319-1332.
29. \+ T cells by a novel cell-based artificial APC. Immunol. Cell Biol. 84, 512-521.
30. Seliger, B., Hammers, S., Höhne, A., Zeidler, R., Knuth, A., Gerharz, C.D., and Huber, C. (1997). IFN-g-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin. Cancer Res. 3, 573-578.
31. Sheaff, R.J., Singer, J.D., Swanger, J., Smitherman, M., Roberts, J.M., and Clurman, B.E. (2000). Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell 5, 403-410.
32. Starodubova, E.S., Boberg, A., Litvina, M., Morozov, A., Petra-kova, N.V., Timofeev, A., Latyshev, O., Tunitskaya, V., Wahren, B., Isaguliants, M.G., and Karpov, V.L. (2008). HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response. Vaccine 26, 5170-5176.
33. Strehl, B., Seifert, U., Krü ger, E., Heink, S., Kuckelkorn, U., and Kloetzel, P.M. (2005). Interferon-g, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 207, 19-30.
34. \+ T cell responses against a cytomegalovirus antigen. J. Immunol. 165, 4105-4111.
35. Varshavsky, A. (2000). Recent studies of the ubiquitin system and the N-end rule pathway. Harvey Lect. 96, 93-116.
36. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Wata-nabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Recon-stitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
37. Whiteside, T.L., Stanson, J., Shurin, M.R., and Ferrone, S. (2004). Antigen-processing machinery in human dendritic cells: Up-regulation by maturation and down-regulation by tumor cells. J. Immunol. 173, 1526-1534.